Clinical diagnosis of PRD proves challenging due to the disease variability, overlapping phenotypes, tissue mosaicism, and the limitations of diagnostic methods, all of which contribute to difficulties in confirming pathogenic PIK3CA gene variants (de Kock et al., 2023). This evidence concerns the gene PIK3CA and X-linked retinal dysplasia.